Offer has to be way above $2 per DLS share before noteholders would gain a benefit. I think conversion price is US$1.76 per share or around A$2.34.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025